Samuel Yang
Faculty
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (20)
Year:
2026
Natural killer (NK) cell antibody-dependent cellular cytotoxicity (ADCC) contributes to effective antiviral immunity, yet the relative contribution of NK cell-intrinsic factors and antibodies in mediating these responses remains poorly understood. Here, we combined functional ADCC assays with single-cell transcriptomics of peripheral NK cells from COVID-19 participants. Our analysis revealed distinct transcriptional programs between participants with different ADCC response levels: NK cells from participants with lower ADCC responses upregulated proliferation pathways, while those with high ADCC responses showed enhanced expression of interferon-stimulated genes and NKG2D. Blocking NKG2D significantly reduced NK cell ADCC degranulation and cytokine responses. Paradoxically, greater interferon-mediated NK cell activation was associated with reduced proficiency of participants' antibodies to mediate ADCC, suggesting a regulatory checkpoint mechanism. These findings enhance our understanding of the molecular determinants of ADCC responses and provide novel insights into leveraging these responses for more effective vaccination and therapeutic strategies.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Noncanonical secondary structures of DNA have been well characterized in vitro for their catalytic and sensory functions, as well as in vivo for their regulatory functions in the genome. However, their presence and functional significance in the extracellular DNA (eDNA), particularly within biofilms and neutrophil extracellular traps (NETs), have only recently begun to be appreciated and have yet to be fully understood. Emerging studies have identified these atypical DNA conformations as integral components that contribute to the structural stability of biofilms and antimicrobial activity of NETs. In this personal view, we advocate for a comprehensive investigation of these unconventional DNA structures within extracellular contexts, where their distinct physiochemical properties are exposed to dynamic and unpredictable microenvironments, with the potential to profoundly influence microbial behaviour, immune responses, and host–pathogen interactions. Considering the broad spectrum of diseases associated with biofilm and NETs, targeting noncanonical eDNA structures may offer novel therapeutic avenues and shed light on mechanisms of immune tolerance and dysregulation.
Year:
2026
Coronavirus disease 2019 (COVID-19) poses significant risks for solid organ transplant recipients, who have atypical but poorly characterized immune responses to infection. We aim to understand the host immunologic and microbial features of COVID-19 in transplant recipients by leveraging a prospective multicenter cohort of 86 transplant recipients age- and sex-matched with 172 non-transplant controls. We find that transplant recipients have higher nasal SARS-CoV-2 viral abundance and impaired viral clearance, and lower anti-spike IgG levels. In addition, transplant recipients exhibit decreased plasmablasts and transitional B cells, and increased senescent T cells. Blood and nasal transcriptional profiling demonstrate unexpected upregulation of innate immune signaling pathways and increased levels of several proinflammatory serum chemokines. Severe disease in transplant recipients, however, is characterized by a less robust induction of pro-inflammatory genes and chemokines. Together, our study reveals distinct immune features and altered viral dynamics in solid organ transplant recipients.
Year:
2025
At this stage in the COVID-19 pandemic, most infections are “breakthrough” infections that occur in individuals with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure. To refine long-term vaccine strategies against emerging variants, we examined both innate and adaptive immunity in breakthrough infections. We performed single-cell transcriptomic, proteomic, and functional profiling of primary and breakthrough infections to compare immune responses from unvaccinated and vaccinated individuals during the SARS-CoV-2 Delta wave. Breakthrough infections were characterized by a less activated transcriptomic profile in monocytes and natural killer cells, with induction of pathways limiting monocyte migratory potential and natural killer cell proliferation. Furthermore, we observed a female-specific increase in transcriptomic and proteomic activation of multiple innate immune cell subsets during breakthrough infections. These insights suggest that prior SARS-CoV-2 vaccination prevents overactivation of innate immune responses during breakthrough infections with discernible sex-specific patterns and underscore the potential of harnessing vaccines in mitigating pathologic immune responses resulting from overactivation.
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2025
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (41)
Holden T. Maecker
Stanford University School of Medicine
Slim Fourati
Assistant Professor
Northwestern University Feinberg School of Medicine
Ryuichiro Abe
Specially Appointed Associate Professor
Research Institute for Microbial Diseases, Osaka University
Bali Pulendran
Emory University
Brandon Lam
-
Justin Rousseau
Associate Professor
University of Texas Southwestern Medical Center
Mehmet Saluvan
Sr. Staff Scientist
Boston Children's Hospital
Arjun Rustagi
Assistant Professor
University of California, San Francisco
Joann Diray Arce
Assistant Professor
Boston Children's Hospital
Albert Ko
Professor of Medicine
Yale University
Alvin Kho
Assistant Professor
Harvard University
Ramin Salehi-Rad
UCLA
Pak Kin Wong
Pennsylvania State University
Catherine Blish
Association Professor
Stanford University School of Medicine
Akiko Iwasaki
Professor
Yale University School of Medicine
Kathleen Mach
Senior Research Scientist
Stanford University
Scott Brakenridge
Professor
University of Washington
Farrah Kheradmand
Professor
Baylor College of Medicine
Michael Wilson
Professor
University of California, San Francisco
Cole Maguire
University of Texas at Austin
Harm van Bakel
Associate Professor
Icahn School of Medicine at Mount Sinai
Nadine Rouphael
Professor with Tenure
Emory University
Al Ozonoff
Associate Professor
Harvard University
Linda N. Geng
Stanford University
John Greenland
Associate Professor
UCSF Medical Center
Lekshmi Santhosh
Associate Professor
University of California
Xiaowu gai
Professor
Medical College of Wisconsin
Michal Caspi Tal
Principal Scientist
Massachusetts Institute of Technology
Joseph Liao
Stanford University
anil sapru
Professor
University of California
Angela Rogers
Professor
University of Texas Southwestern Medical Center
Jennifer A. Newberry
Stanford University
Hiromitsu Asashima
University of Tsukuba
George A Yendewa
Assistant Professor
Case Western Reserve University School of Medicine
Nathan Grubaugh
Associate Professor
Yale School of Public Health
Susan Holmes
Professor
Stanford University
Michele Kutzler
Professor of Medicine and Microbiology and Immunology
Drexel University
Boryana Petrova
Head of Research Metabolomics
Medical University of Vienna
Erin Scherer
Associate Professor
Emory University
Edward Vincent S. Faustino
Professor of Pediatrics (Critical Care)
Yale University School of Medicine
Stephanie Shiau
Associate Professor
Rutgers University
Make your next move.
Prepare your application
Review drafts before you send them.